A Riyadh hospital cannot treat an overseas quotation for Valif 20 mg as proof that the product is authorised for Saudi use. By checking SFDA registration, clinical restrictions, product identity, supplier documents and landed-delivery terms, a procurement team can decide whether to reject, approve or conditionally evaluate an offer.
Key takeaways
- Confirm SFDA eligibility before requesting a hospital quotation.
- Screen vardenafil prescriptions for dose, contraindications and interactions.
- Match the formulation, strength and counselling controls to hospital use.
- Compare landed compliance costs, not only the tablet price.
Confirm SFDA eligibility before requesting a hospital quotation
A hospital should confirm SFDA eligibility before requesting a quotation from a Valif 20 mg supplier in Riyadh. The product must be legally eligible for import, sale and hospital use in Saudi Arabia, not merely available through a search for “buy valif tablets.”
1. Request the SFDA marketing-authorisation or registration number, registered product name, vardenafil 20 mg strength, exact dosage form, marketing-authorisation holder and authorised Saudi representative. Match every detail against the SFDA record and proposed pack artwork.
2. Confirm the Saudi importer of record and identify who handles customs clearance, pharmacovigilance, recalls and complaints. An Indian-market brand name, overseas export licence or manufacturer statement does not establish Saudi approval.
3. Write the purchase specification as vardenafil 20 mg per tablet, immediate-release film-coated tablet, or the exact registered form. Add pack size, manufacturer, country of manufacture, batch number, remaining shelf life, storage statement and SFDA registration status.
Do not issue a purchase order until the regulatory identity, local representative and import route are documented. Treat informal marketplace listings and “buy valif tablets” results as lead generation only; they do not prove lawful supply.
State in the tender that any substitution involving the manufacturer, dosage form, pack artwork or registration status requires written hospital approval and fresh regulatory verification. Reject a quotation that cannot connect the proposed pack to the current SFDA record and a documented Saudi import pathway.
Screen the prescription, dose and interaction risks
Route every order through the licensed hospital service responsible for the indication, such as urology or men’s health, and require a credentialed prescriber under the hospital formulary. Treat vardenafil as a prescription medicine, not an open wholesale item.
The usual adult starting dose is 10 mg about 60 minutes before sexual activity; adjust for response and tolerability, with no more than one dose in 24 hours.
| Strength | Procurement interpretation | Control |
|---|---|---|
| 10 mg | Usual adult starting strength | Dispense after prescription and interaction review |
| 20 mg | Maximum recommended single dose in US prescribing information, not a universal starting strength | Require documented prescriber selection |
| Lower starting dose | Relevant for moderate hepatic impairment or interaction risk | Follow the applicable product label |
Before pharmacy approval, screen for:
- Organic nitrates and nitric-oxide donors, including nitroglycerin; the combination can cause dangerous hypotension.
- Riociguat; do not use vardenafil with it.
- Alpha-blockers and other antihypertensives; additive blood-pressure lowering requires prescriber review.
- Strong CYP3A4 inhibitors, including ritonavir, cobicistat, ketoconazole and itraconazole; apply the label’s dose restriction or avoidance instruction.
- Congenital QT prolongation and Class IA or Class III antiarrhythmics; avoid vardenafil.
- Severe hepatic impairment or renal dialysis; use is not recommended. Consider a lower starting dose in moderate hepatic impairment.
A vardenafil tablet supplier’s certificate of analysis cannot replace this clinical screening. The pharmacy should block substitution or dispensing when the prescription conflicts with these controls.
Choose the right strength, formulation and counselling controls
Procure 20 mg only for patients whose prescriber considers the maximum single dose appropriate; it is not the universal starting strength. Compare the available strengths before approving a hospital pack:
| Strength | Procurement role | Key control |
|---|---|---|
| 5 mg | Cautious titration | Prefer when tolerability or interaction concerns require a lower starting dose |
| 10 mg | Usual adult starting option | Adjust according to response and tolerability |
| 20 mg | Maximum recommended single dose | Reserve for prescriber-approved escalation; never treat as routine initiation |
Choose 5 mg or 10 mg for older patients with tolerability concerns, interacting medicines, moderate hepatic impairment, or renal limitations identified by the prescriber. Vardenafil is not recommended in severe hepatic impairment or for patients on renal dialysis.
Confirm that the registered product is a conventional immediate-release film-coated tablet, an orally disintegrating tablet, or another modified presentation. Do not substitute presentations without written approval: administration instructions, excipients, packaging and bioequivalence evidence can differ despite the same 20 mg label.
Consider another PDE5 inhibitor when the interaction profile, dosing schedule, adverse-effect history, formulary policy or clinical response makes vardenafil unsuitable; the prescriber must choose it. Before dispensing, assess fitness for sexual activity, especially with unstable cardiac disease.
Counselling and triage materials must direct urgent care for an erection lasting more than four hours, sudden vision or hearing loss, chest pain, fainting or severe cardiovascular symptoms.
Authenticate the packs and qualify the vardenafil supplier
Reject the shipment if the pack cannot be matched to the approved SFDA record and source documents. A plausible-looking Valif pack is not enough: counterfeit, mislabelled and unregistered products can carry the correct 20 mg claim.
| Check | Match against | Reject if |
|---|---|---|
| Manufacturer | Approved manufacturer and country of manufacture | Name differs or is misspelled |
| Medicine | Vardenafil, 20 mg per tablet, exact dosage form | Ingredient, strength or form is altered |
| Identification | Batch number and expiry date | Data is missing, overprinted or inconsistent |
| Security | Tamper-evident seal and pack condition | Seal is broken or label has been altered |
| Presentation | Registered pack artwork and leaflet | Colours, logos, wording or instructions differ |
Request these records from every vardenafil tablet supplier:
- Commercial invoice and packing list
- Batch-specific certificate of analysis and batch-release information
- Certificate of Pharmaceutical Product or equivalent regulatory document
- Manufacturing licence and current GMP evidence
- Product specification and stability or shelf-life support
- Arabic or English package leaflet required by the hospital process
- Transport records when heat, humidity or handling could affect the shipment
The certificate of analysis demonstrates batch conformity; it does not prove Saudi market eligibility. Verify the SFDA registration number, registered product name, marketing-authorisation holder and authorised Saudi representative separately. An Indian manufacturer’s export capability does not authorise direct hospital supply in Saudi Arabia.
NIBA HEALTHCARE, considered as a Valif 20 mg exporter, should provide these records before qualification, while the hospital verifies the Saudi importer or authorised representative independently. An overseas export licence cannot replace that local regulatory pathway.
Related product
![]() | VARDENAFIL TABLET 20MG Valif 20 Tablet is used to treat erectile dysfunction in men. It increases blood flow to the penis to help men get an erection. View product → |
Compare wholesale offers on landed compliance, not tablet price
Compare vardenafil 20 mg wholesale quotations only after converting them to the same Riyadh-delivered basis. A low ex-factory tablet price is not comparable with an offer that includes clearance, freight and replacement risk.
| Quotation field | Offer A | Offer B |
|---|---|---|
| Product basis | Vardenafil 20 mg per tablet, approved immediate-release film-coated tablet | Same dosage form and approved pack size |
| Delivery basis | Same Incoterm, Riyadh delivery point, freight, insurance and customs responsibility | Same Incoterm, Riyadh delivery point, freight, insurance and customs responsibility |
| Supply evidence | Batch availability, release status, shelf life at delivery and document lead time | Same batch and document information |
| Risk ownership | Clearance delays, rejected batches, regulatory changes, damage and temperature excursions | Same responsibilities stated in writing |
Put these fields in the request for quotation and purchase order:
- Minimum order quantity and pack configuration
- Remaining shelf life at delivery
- Saudi importer of record and authorised Saudi entity
- Replacement period for damaged packs or temperature excursions
- Recall contact, complaint contact and escalation route
- Named owner for clearance delays, rejected batches and regulatory changes
Follow the approved label’s storage statement. Do not require refrigeration unless the label requires it; control excessive heat and humidity, requesting temperature or humidity records when the route, season or shipment risk justifies them.
A Valif 20 mg exporter must identify its authorised Saudi supply route; an overseas export licence is not local permission. Approve only after pharmacy, regulatory, quality and finance sign off on the same product and delivery terms.
Frequently asked questions
Why confirm SFDA eligibility before requesting a Valif quotation?
A hospital must confirm that Valif 20 mg is eligible for import, sale and use in Saudi Arabia before evaluating a vardenafil tablet supplier or requesting a quotation.
What should hospitals screen before supplying vardenafil 20 mg?
Screen the prescription, prescribed dose and interaction risks before dispensing, with particular attention to whether the patient’s medicines or clinical circumstances make vardenafil unsuitable.
How should a hospital choose the right Valif strength and formulation?
Compare the prescribed strength and formulation with the hospital’s use case, then establish counselling and dispensing controls that reduce dose-selection errors.
How can procurement teams qualify a Valif 20 mg exporter?
Authenticate the packs and review the supplier’s documentation, traceability and ability to provide compliant stock before treating an offer as suitable for hospital procurement.
How should hospitals compare vardenafil 20 mg wholesale offers?
Compare the landed cost of compliant stock, including documentation and import requirements, rather than ranking suppliers by tablet price alone.
